These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6749531)

  • 1. Comparison of the potencies of some prostaglandins as vasodilators in three vascular beds of the anaesthetised dog.
    Lumley P; Humphrey PP; Kennedy I; Coleman RA
    Eur J Pharmacol; 1982 Jul; 81(3):421-30. PubMed ID: 6749531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular actions of prostacyclin (PGI2) in the cat.
    Lippton HL; Paustian PW; Mellion BT; Nelson PK; Feigen LP; Chapnick BM; Hyman AL; Kadowitz PJ
    Arch Int Pharmacodyn Ther; 1979 Sep; 241(1):121-30. PubMed ID: 393193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-Keto-prostaglandin E1 is more potent than prostaglandin I2 as a renal vasodilator and renin secretagogue.
    Jackson EK; Herzer WA; Zimmerman JB; Branch RA; Oates JA; Gerkens JF
    J Pharmacol Exp Ther; 1981 Jan; 216(1):24-7. PubMed ID: 7005428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary and systemic vasodilator effects of the newly discovered prostaglandin, PGI2.
    Kadowitz PJ; Chapnick BM; Feigen LP; Hyman AL; Nelson PK; Spannhake EW
    J Appl Physiol Respir Environ Exerc Physiol; 1978 Sep; 45(3):408-13. PubMed ID: 359514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary vasodilator activity of prostacyclin (PGI2) in the cat.
    Hyman AL; Kadowitz PJ
    Circ Res; 1979 Sep; 45(3):404-9. PubMed ID: 110490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandins and cyclic nucleotides: effects of PGI2 and PGE1 on cardiac hemodynamic and coronary arterial and myocardial cyclic nucleotide levels in dogs.
    Ito T; Ogawa K; Enomoto I; Hashimoto H; Kai I; Sakai K; Satake T
    Jpn Circ J; 1980 Sep; 44(9):755-61. PubMed ID: 6251292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular actions of arachidonic acid and its metabolites in perfused mesenteric and femoral beds of the dog.
    Dusting GJ; Moncada S; Vane JR
    Eur J Pharmacol; 1978 May; 49(1):65-72. PubMed ID: 350595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral vasodilator effects of prostaglandins: comparison of 6-keto-prostaglandin E1 with prostacyclin and escape from prostaglandin E2 in the mesenteric vascular bed.
    Feigen LP; Chapnick BM; Hyman AL; King L; Marascalco B; Kadowitz PJ
    J Pharmacol Exp Ther; 1980 Sep; 214(3):528-34. PubMed ID: 6995573
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostacyclin (PGI2) induces coronary vasodilatation in anaesthetised dogs.
    Dusting GJ; Chapple DJ; Hughes R; Moncada S; Vane JR
    Cardiovasc Res; 1978 Dec; 12(12):720-30. PubMed ID: 376143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasodilation produced by prostacyclin (PGI2) and 9(O)-thiaprostacyclin (PGI2-S) in the canine femoral circulation.
    Horii D; Kanayama T; Mori M; Shibasaki M; Ikegami S
    Eur J Pharmacol; 1978 Oct; 51(3):313-6. PubMed ID: 361420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary vasodilator activity of 13,14-dehydroprostacyclin methyl ester: comparison with prostacyclin and other prostanoids.
    Hyman AL; Kadowitz PJ; Lands WE; Crawford CG; Fried J; Barton J
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3522-6. PubMed ID: 356056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placental vascular responses to 6-keto-prostaglandin E1 in the near-term sheep.
    Schwartz DB; Phernetton TM; Stock MK; Rankin JH
    Am J Obstet Gynecol; 1983 Feb; 145(4):406-10. PubMed ID: 6337494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of prostaglandins in the pulmonary microcirculation.
    Ogletree ML
    Ann N Y Acad Sci; 1982; 384():191-206. PubMed ID: 7046563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasodilator actions of prostaglandin 6-keto-E1 in the pulmonary vascular bed.
    Hyman AL; Kadowitz PJ
    J Pharmacol Exp Ther; 1980 Jun; 213(3):468-72. PubMed ID: 7193724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of some pharmacological actions of prostaglandin E1, 6-oxo-PGE1 and PGI2.
    Adaikan PG; Tai NY; Lau LC; Karim SM; Kottegoda SR
    Prostaglandins; 1984 Apr; 27(4):505-16. PubMed ID: 6203140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective antagonism of the systemic vasodepressor response to PGE1 by d,1-11, 15-bisdeoxy PGE1.
    Stinger RB; Fitzpatrick TM; Van Dam J; Ramwell PW; Kot PA
    Prostaglandins; 1980 Feb; 19(2):213-20. PubMed ID: 6992223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-keto-PGE1 exhibits more potent bronchodilatory activity in the cat than its precursor, PGI2.
    Spannhake EW; Levin JL; Hyman AL; Kadowitz PJ
    Prostaglandins; 1981 Feb; 21(2):267-75. PubMed ID: 7012934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative studies on the hemodynamic effects of prostaglandin E1 prostacyclin, and tolazoline upon elevated pulmonary vascular resistance in neonatal swine.
    Starling MB; Neutze JM; Elliott RL; Elliott RB
    Prostaglandins Med; 1981 Nov; 7(5):349-61. PubMed ID: 7034018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the vasodepressor action of ZK 36 374, a stable prostacyclin derivative, PGI2 and PGE1 with their effect on platelet aggregation and bleeding time in rats.
    Casals-Stenzel J; Buse M; Losert W
    Prostaglandins Leukot Med; 1983 Feb; 10(2):197-212. PubMed ID: 6189133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of certain vasodilating prostaglandins on the coronary and hindlimb vascular beds of the conscious sheep.
    Carter J; Reynoldson JA; Thorburn GD
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1986; 83(2):401-6. PubMed ID: 2872005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.